IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 117 filers reported holding IMMUNOVANT INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,500 | -4.2% | 221,400 | -52.7% | 0.01% | +7.7% |
| Q2 2023 | $8,874 | +16.3% | 467,800 | -4.9% | 0.01% | +30.0% |
| Q1 2023 | $7,633 | +25.0% | 492,112 | +43.0% | 0.01% | +25.0% |
| Q4 2022 | $6,108 | -99.7% | 344,100 | -2.4% | 0.01% | +166.7% |
| Q3 2022 | $1,967,000 | +51.7% | 352,500 | +6.0% | 0.00% | +50.0% |
| Q2 2022 | $1,297,000 | +133.7% | 332,600 | +230.3% | 0.00% | +100.0% |
| Q1 2022 | $555,000 | +270.0% | 100,700 | +472.2% | 0.00% | – |
| Q4 2021 | $150,000 | -42.1% | 17,600 | +214.3% | 0.00% | – |
| Q4 2020 | $259,000 | -70.7% | 5,600 | -84.6% | 0.00% | -100.0% |
| Q2 2020 | $884,000 | – | 36,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |